TIAA CREF Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$528K	Buy	100,555 +32,043	+47%	+$183K	﹤0.01%	2578
2018 Q4	$305K	Buy	68,512 +35,200	+106%	+$193K	﹤0.01%	2767
2018 Q3	$269K	Buy	33,312 +3,503	+12%	+$25K	﹤0.01%	2913
2018 Q2	$209K	Sell	29,809 -68,230	-70%	-$669K	﹤0.01%	3028
2018 Q1	$1.4M	Buy	98,039 +44,655	+84%	+$474K	﹤0.01%	2280
2017 Q4	$468K	Buy	53,384 +3,304	+7%	+$32.7K	﹤0.01%	2802
2017 Q3	$586K	Buy	50,080 +596	+1%	+$7.31K	﹤0.01%	2766
2017 Q2	$691K	Buy	49,484 +26,560	+116%	+$304K	﹤0.01%	2716
2017 Q1	$315K	Buy	22,924 +6,091	+36%	+$63.3K	﹤0.01%	2915
2016 Q4	$121K	Buy	16,833 +6,073	+56%	+$66.6K	﹤0.01%	3077
2016 Q3	$163	Sell	10,760 -539	-5%	-$7.09K	﹤0.01%	3066
2016 Q2	$111K	Buy	+11,299	New	+$155K	﹤0.01%	3129